In This Article:
Herantis Pharma Oyj: Manager`s Transactions - Pekka Simula
Herantis Pharma Plc
Company release 22 October 2018 at 9:00 am
Herantis Pharma Oyj - Managers` Transactions
____________________________________________
Person subject to the notification requirement
Name: Pekka Simula
Position: Chief Executive Officer
Issuer: Herantis Pharma Oyj
LEI: 743700W4CQVYAT3WKK38
Notification type: INITIAL NOTIFICATION
Reference number: 743700W4CQVYAT3WKK38_20181020161010_2
____________________________________________
Transaction date: 2018-10-18
Venue: FIRST NORTH FINLAND (FNFI)
Instrument type: SHARE
ISIN: FI4000087861
Nature of the transaction: ACQUISITION
Transaction details
(1): Volume: 200 Unit price: 5.55 EUR
(2): Volume: 200 Unit price: 5.3 EUR
Aggregated transactions
(2): Volume: 400 Volume weighted average price: 5.425 EUR
____________________________________________
Transaction date: 2018-10-19
Venue: FIRST NORTH FINLAND (FNFI)
Instrument type: SHARE
ISIN: FI4000087861
Nature of the transaction: ACQUISITION
Transaction details
(1): Volume: 200 Unit price: 5.95 EUR
Aggregated transactions
(1): Volume: 200 Volume weighted average price: 5.95 EUR
____________________________________________
Further information:
Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, telephone: +358 9 25 380 225
Distribution:
Nasdaq Helsinki
Main media
www.herantis.com
This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Herantis Pharma Oyj via GlobeNewswire
HUG#2221373